SETD2 and neoplasm: Generally speaking, in gastrointestinal stromal tumors (GIST) functional consequences of SETD2 mutations were investigated in primary tissues and cell lines and SETD2 has been described as a novel GIST tumor suppressor gene associated with disease progression [83].